Search Within

Mark Frattini

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (7)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (19)
  2. Sloan Kettering Institute Faculty (19)
  3. Department of Medicine (18)
  4. GSK Faculty (18)
  5. Hematologic Malignancies, Division of (18)
  6. Adult Leukemia (17)

More Groups

People
  1. David Scheinberg (12)
  2. Joseph Jurcic (12)
  3. Peter Maslak (10)
  4. Renier Brentjens (10)
  5. Suzanne Chanel (7)
  6. Todd Rosenblat (7)

More People

Years
  1. 2018 (1)
  2. 2016 (1)
  3. 2014 (1)
  4. 2013 (1)
  5. 2012 (4)
  6. 2011 (6)

More Years

Publications
  1. Blood (9)
  2. Journal of Clinical Oncology (4)
  3. Bioorganic & Medicinal Chemistry Letters (2)
  4. Blood Advances (1)
  5. Clinical Lymphoma, Myeloma and Leukemia (1)
  6. Molecular Neurodegeneration (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. American Society of Clinical Oncology (4)
  3. Pergamon-Elsevier Science Ltd (2)
  4. American Association for the Advancement of Science (1)
  5. Biomed Central Ltd (1)
  6. Elsevier Inc. (1)

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR)
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M. G.; Rosenblat, T. L.; Jurcic, J. G.; Rampal, R.; Park, J. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
    Journal Article

    Brentjens, R. J.; Davila, M. L.; Riviere, I.; Park, J.; Wang, X.; Cowell, L. G.; Bartido, S.; Stefanski, J.; Taylor, C.; Olszewska, M.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • A phase I clinical trial of autologous, anti-CD19 gene targeted T cells for adults with B cell acute lymphoblastic leukemia (B-ALL)
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; Taylor, C.; Olszewska, M.; Borquez-Ojeda, O.; Qu, J.; Wasielewska, T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in patients with acute myeloid leukemia (AML) in complete remission (CR)
    Meeting Abstract

    Rosenblat, T. L.; Frattini, M. G.; Chanel, S. M.; Dao, T.; Bernal, Y.; Jurcic, J. G.; Zhang, R.; Simancek, P.; Tallman, M. S.; Scheinberg, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Aerobic glycolysis predicts outcome in early chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S.; Knapp, K.; Bauli, F.; Lamanna, N.; Frattini, M. G.; Brentjens, R. J.; Maslak, P. G.; Jurcic, J. G.; Weiss, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Molecular remission and B cell aplasia induced in a first cohort of adults with relapsed B-ALL treated with 19-28z CAR-targeted T cells
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X. Y.; Park, J. H.; Stefanski, J.; Taylor, C.; He, Q.; Olszewska, M.; Wasielewska, T.; Borquez-Ojeda, O.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac-lintuzumab) (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Ryan, C.; Frattini, M. G.; Cicic, D.; Larson, S. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Lymphodepletion and tumor burden govern clinical responses in patients with B-cell malignancies treated with autologous, CD19-targeted T cells
    Meeting Abstract

    Brentjens, R. J.; Riviere, I.; Park, J.; Davilla, M.; Wang, X.; Yeh, R.; Lamanna, N.; Frattini, M. G.; Sadelain, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save